Breaking News, Promotions & Moves

PCI Synthesis Appoints R&D VP

Tretyakov to provide technical leadership across the company

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Alexander Tretyakov has been appointed vice president of R&D at PCI Synthesis, Inc. Mr. Tretyakov will provide technical leadership across the company, specifically in creating de novo synthetic schemes and approaches. He will work with customers to provide oversight and professional development opportunities for the R&D department.
 
Prior to joining the company, Mr. Tretyakov spent nine years at Cambridge Major Laboratories, where he served most recently as vice president of R&D. Previously he launched Omega Engineering, providing custom synthesis solutions to the pharmaceutical and fine chemical industries. Prior to that he held roles as plant chemist, pilot plan operations supervisor, scientist and chemical engineer at various chemical manufacturers.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters